1. Home
  2. BGX vs BWAY Comparison

BGX vs BWAY Comparison

Compare BGX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGX
  • BWAY
  • Stock Information
  • Founded
  • BGX 2010
  • BWAY 2003
  • Country
  • BGX United States
  • BWAY Israel
  • Employees
  • BGX N/A
  • BWAY N/A
  • Industry
  • BGX Trusts Except Educational Religious and Charitable
  • BWAY Medical/Dental Instruments
  • Sector
  • BGX Finance
  • BWAY Health Care
  • Exchange
  • BGX Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • BGX 163.6M
  • BWAY 159.3M
  • IPO Year
  • BGX N/A
  • BWAY 2019
  • Fundamental
  • Price
  • BGX $12.75
  • BWAY $9.12
  • Analyst Decision
  • BGX
  • BWAY Buy
  • Analyst Count
  • BGX 0
  • BWAY 4
  • Target Price
  • BGX N/A
  • BWAY $13.17
  • AVG Volume (30 Days)
  • BGX 67.9K
  • BWAY 86.3K
  • Earning Date
  • BGX 01-01-0001
  • BWAY 11-12-2024
  • Dividend Yield
  • BGX 10.34%
  • BWAY N/A
  • EPS Growth
  • BGX N/A
  • BWAY N/A
  • EPS
  • BGX N/A
  • BWAY 0.04
  • Revenue
  • BGX N/A
  • BWAY $38,631,000.00
  • Revenue This Year
  • BGX N/A
  • BWAY $378.91
  • Revenue Next Year
  • BGX N/A
  • BWAY $20.27
  • P/E Ratio
  • BGX N/A
  • BWAY $117.82
  • Revenue Growth
  • BGX N/A
  • BWAY 34.19
  • 52 Week Low
  • BGX $10.69
  • BWAY $4.56
  • 52 Week High
  • BGX $12.44
  • BWAY $10.98
  • Technical
  • Relative Strength Index (RSI)
  • BGX 51.42
  • BWAY 41.64
  • Support Level
  • BGX $12.60
  • BWAY $8.96
  • Resistance Level
  • BGX $12.99
  • BWAY $10.98
  • Average True Range (ATR)
  • BGX 0.11
  • BWAY 0.57
  • MACD
  • BGX 0.01
  • BWAY -0.18
  • Stochastic Oscillator
  • BGX 41.46
  • BWAY 19.83

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategy in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first- and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: